Cargando...
Breaking Bottlenecks for the TCR Therapy of Cancer
Immune checkpoint inhibitors have redefined the treatment of cancer, but their efficacy depends critically on the presence of sufficient tumor-specific lymphocytes, and cellular immunotherapies develop rapidly to fill this gap. The paucity of suitable extracellular and tumor-associated antigens in s...
Guardado en:
| Publicado en: | Cells |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7564186/ https://ncbi.nlm.nih.gov/pubmed/32937956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9092095 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|